// App-Quantinova.ai

1236 : ONC201 sensitivity profiling indicates pronounced sensitivity in lymphoid, prostate, colon and brain tumors

Researchers

Presenter

  • Rohinton Tarapore

Principal Investigators

  • Mathew Garnett

  • Ultan McDermott

  • Cyril Benes

  • Joshua Allen

Medical Centers

  • Oncoceutics, Philadelphia, PA

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

  • United Kingdom

Companies

  • Wellcome Sanger Inst

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Unspecified Cancer

  • Brain cancer

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • TIC 10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved